Pfizer powers ahead in 2026 with strong Q1 results as pipeline momentum builds

The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook

Swasth Bharat Portal launched by Jagat Prakash Nadda

Conceptualized as an aggregator platform it integrates existing programme systems through an API-based federated architecture

Dr Odin launches ‘Odin Buddy’ kids’ nebulizer for child-friendly respiratory care

New pediatric nebulizer combines playful design and engaging features to make breathing treatments less stressful for children and parents

World Asthma Day: Apollo Spectra Hospital urges early diagnosis and treatment adherence

Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India

Lupin receives USFDA approval for generic Ravicti oral liquid

Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders

SetPoint Medical launches first-in-human MS pilot study using implanted nerve stimulation device

India unveils first-ever national framework to tackle childhood diabetes

New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system

OneSource Specialty Pharma's partners get Health Canada approval for generic Semaglutide injection

Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing

Health ministry releases new healthcare safety guidelines

Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities

FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer

The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor